SG11201708158PA - Composition for suppressing muscular fatty change - Google Patents
Composition for suppressing muscular fatty changeInfo
- Publication number
- SG11201708158PA SG11201708158PA SG11201708158PA SG11201708158PA SG11201708158PA SG 11201708158P A SG11201708158P A SG 11201708158PA SG 11201708158P A SG11201708158P A SG 11201708158PA SG 11201708158P A SG11201708158P A SG 11201708158PA SG 11201708158P A SG11201708158P A SG 11201708158PA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- fatty change
- suppressing muscular
- muscular
- suppressing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015090580 | 2015-04-27 | ||
PCT/JP2016/062700 WO2016175136A1 (en) | 2015-04-27 | 2016-04-22 | Composition for suppressing muscular fatty change |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201708158PA true SG11201708158PA (en) | 2017-11-29 |
Family
ID=57198430
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201909412R SG10201909412RA (en) | 2015-04-27 | 2016-04-22 | Composition for suppressing muscular fatty change |
SG11201708158PA SG11201708158PA (en) | 2015-04-27 | 2016-04-22 | Composition for suppressing muscular fatty change |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201909412R SG10201909412RA (en) | 2015-04-27 | 2016-04-22 | Composition for suppressing muscular fatty change |
Country Status (8)
Country | Link |
---|---|
US (1) | US20180104269A1 (en) |
JP (1) | JP7013238B2 (en) |
CN (1) | CN107530320A (en) |
CA (1) | CA2982645C (en) |
HK (1) | HK1246182A1 (en) |
SG (2) | SG10201909412RA (en) |
TW (1) | TW201713330A (en) |
WO (1) | WO2016175136A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018087175A (en) * | 2016-11-30 | 2018-06-07 | 花王株式会社 | Muscular atrophy inhibitor |
SG11201907472QA (en) * | 2017-03-10 | 2019-09-27 | Suntory Holdings Ltd | Composition for inhibiting myofibrosis |
WO2019208627A1 (en) * | 2018-04-27 | 2019-10-31 | サントリーホールディングス株式会社 | Composition for preventing decrease in muscle mass, preventing decrease in muscular power, increasing muscle mass or enhancing muscular power |
CN114745967A (en) * | 2019-11-27 | 2022-07-12 | 三得利控股株式会社 | Composition for inhibiting decrease in muscle mass, inhibiting decrease in muscle strength, increasing muscle mass or increasing muscle strength |
CN114958730A (en) * | 2022-04-22 | 2022-08-30 | 南京农业大学 | Muscle stem cell proliferation medium, differentiation medium and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100441590C (en) * | 2006-03-10 | 2008-12-10 | 中山大学 | Compounds like quercetol and metal complex of their glycosides and uses |
JP2008255075A (en) * | 2007-04-09 | 2008-10-23 | Daidoo Dorinko Kk | Improving agent for vessel endothelium function and health food |
JP2013126951A (en) * | 2010-03-01 | 2013-06-27 | Kyushu Univ | Muscular atrophy inhibitor |
JP2014015428A (en) * | 2012-07-10 | 2014-01-30 | Kao Corp | Satellite cell differentiation promoter |
JP2014037387A (en) * | 2012-08-18 | 2014-02-27 | Kobe Gakuin | Therapeutic agent for muscular dystrophy |
SG11201608760WA (en) * | 2014-04-28 | 2016-11-29 | Suntory Holdings Ltd | Muscle atrophy inhibitor containing quercetin glycoside |
-
2016
- 2016-04-22 JP JP2017515526A patent/JP7013238B2/en active Active
- 2016-04-22 SG SG10201909412R patent/SG10201909412RA/en unknown
- 2016-04-22 WO PCT/JP2016/062700 patent/WO2016175136A1/en active Application Filing
- 2016-04-22 US US15/568,810 patent/US20180104269A1/en not_active Abandoned
- 2016-04-22 CA CA2982645A patent/CA2982645C/en active Active
- 2016-04-22 CN CN201680023112.6A patent/CN107530320A/en active Pending
- 2016-04-22 SG SG11201708158PA patent/SG11201708158PA/en unknown
- 2016-04-26 TW TW105112956A patent/TW201713330A/en unknown
-
2018
- 2018-05-03 HK HK18105727.9A patent/HK1246182A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN107530320A (en) | 2018-01-02 |
TW201713330A (en) | 2017-04-16 |
JPWO2016175136A1 (en) | 2018-02-15 |
SG10201909412RA (en) | 2019-11-28 |
JP7013238B2 (en) | 2022-01-31 |
HK1246182A1 (en) | 2018-09-07 |
WO2016175136A1 (en) | 2016-11-03 |
US20180104269A1 (en) | 2018-04-19 |
CA2982645C (en) | 2024-02-13 |
CA2982645A1 (en) | 2016-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201512030D0 (en) | Composition | |
GB201521507D0 (en) | Composition | |
GB201506827D0 (en) | Composition | |
HK1246182A1 (en) | Composition for suppressing muscular fatty change | |
LT3273947T (en) | Composition for ocular health | |
GB201515640D0 (en) | Composition | |
GB201506830D0 (en) | Composition | |
GB201506829D0 (en) | Composition | |
GB201506825D0 (en) | Composition | |
GB201517546D0 (en) | Composition | |
GB201506828D0 (en) | Composition | |
GB201518348D0 (en) | Composition | |
GB201514585D0 (en) | Composition | |
GB201511697D0 (en) | Composition | |
GB201509044D0 (en) | Composition | |
GB201505520D0 (en) | Composition | |
GB201504665D0 (en) | Composition | |
PL3347444T3 (en) | Fat compositions | |
PL3344070T3 (en) | Edible composition | |
GB201519327D0 (en) | Composition | |
GB201515639D0 (en) | Composition | |
GB201508722D0 (en) | Composition | |
GB201506826D0 (en) | Composition | |
GB201521384D0 (en) | Composition | |
GB201520125D0 (en) | Composition |